1Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science.
Raloxifene, a selective estrogen-receptor modulator, shows potential in improving cognitive function for postmenopausal women with osteoporosis. Further research into novel SERMs for cognitive enhancement is anticipated.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: